A new, stricter framework of self-regulation within the industry was unveiled this month by the board of the Hellenic Association of Pharmaceutical Companies (SFEE), at a special event under the auspices of the Ministry of Health, where an updated Code of Ethics was presented.
The revised Code of Ethics sets out a series of "tight" regulations in the promotion of prescribed medicines, establishes a "ceiling" on sponsorships for conferences, and creates specific conditions for the participation of health professionals in conferences.
Furthermore, the revision responds to the need to set specific limits on donations, to establish criteria in terms of market research and to clarify some aspects regarding the rendering of consultancy services.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze